Summary: Researchers mapped the molecular landscapes of autism spectrum disorder (ASD) to determine how hundreds of diverse genetic mutations affect the developing brain. The study utilized single-nucleus multi-omics sequencing to track gene expression and epigenetic shifts across 250+ distinct tissue samples.
The team discovered that while different genetic models carry distinct molecular fingerprints, they ultimately converge on the exact same brain cell types and biological pathways during early development. These shared changes present primarily as temporary, transient delays in cellular maturation and neural connectivity rather than permanent structural defects, with many differences fading two weeks after birth.
The study revealed that female models display vastly different molecular responses to ASD-linked mutations than males. These findings show that a universal, one-size-fits-all treatment is biologically unviable, signaling a major paradigm shift toward stage-, sex-, and trajectory-specific early interventions.
Key Facts
- Convergent Brain Pathways: Researchers discovered that highly diverse genetic mutations linked to autism converge on the same brain cell types and molecular processes during early development.
- Transient Maturation Delays: The structural and molecular changes mostly present as temporary, transient delays in cell maturation and connectivity rather than permanent biological defects.
- Sex-Specific Variations: Female models showed entirely different molecular and cellular responses to high-risk ASD mutations compared to male models.
- Multi-Omics Mapping: The project analyzed more than 250 individual cell-nucleus samples to concurrently track DNA, RNA activity, and epigenetic modifications at a single-cell level.
- Targeted Intervention Window: Because many shared developmental differences begin to fade two weeks after birth in preclinical models, the findings highlight a critical, time-sensitive window for early therapies.
Source: ISTA
Hundreds of genes have been linked to autism, yet the precise molecular and cellular mechanisms behind it remain largely unclear.
A new study published in Nature, led by Gaia Novarino at the Institute of Science and Technology Austria (ISTA), aims to uncover these mechanisms—and in doing so, might lay the groundwork for developing medical therapies.
“Autism spectrum conditions, often abbreviated as ASD in scientific and medical literature, are, for example, neurodevelopmental disorders such as epilepsy or intellectual disability. The underlying changes begin during early brain development, while the first signs often become apparent in early childhood and can persist throughout life,” explains Gaia Novarino, Professor and Executive Vice President at the Institute of Science and Technology Austria (ISTA).
A key question in the field has long been whether the many genetic causes of ASD ultimately converge on the same biological changes in the brain. ISTA alum Lena Schwarz and colleagues from the Novarino group at ISTA, the Medical University of Vienna, the University of Vienna, and CeMM have now found clues.
Plenty of mutations, plenty of data
Autism is a genetically complex disorder. While some cases are linked to rare mutations in individual genes, others involve a broader combination of factors. “That makes the biology much more complex,” says Schwarz.
For her PhD project, she asked whether different autism-associated genetic mutations might nevertheless affect brain development in related ways. By comparing molecular changes across several genetic models and developmental stages, this project aimed to identify where these mutations share biological pathways and where they leave their own distinct molecular signature.
“With such an overview, we wanted to understand whether different genetic causes of autism might still lead to overlapping effects—and where their effects differ.” A daunting task involving truly massive amounts of data.
Just ten years ago, such an analysis would have been unthinkable. But technological advances have now made it possible. The researchers turned to a method known as single‑nucleus multi‑omics sequencing—a complex-sounding name that can be broken down.
Instruction manual and activity log of individual nerve cells
“Single nucleus” refers to the cell nucleus—a cell’s control center that contains its DNA. The brain contains many cell types. By looking at individual nuclei, researchers can distinguish these cell types and examine what is happening inside them more precisely.
“Multi‑omics” means looking at several layers of information within that nucleus: the DNA itself, the gene activity through RNA, and the epigenome—chemical modifications on the DNA that regulate whether a gene is switched on or off.
This approach offers major advantages for questions like those posed by Schwarz and Novarino. Instead of working with bulk samples, the team can study individual cells to determine which mutations affect which cell types and how autism‑related genes show distinct patterns in the brain.
For Schwarz, that meant analyzing more than 250 samples covering high‑risk ASD genes in two different brain regions—from both male and female mice at various developmental stages.
Different mutations, same molecular effects during brain development
The researchers discovered that although the impacted genes varied, the same brain cell types and molecular processes were affected across models—particularly during early brain development in the mice. At the same time, each model showed its own molecular fingerprint.
These changes mostly appeared as transient delays in cell maturation and connectivity rather than permanent defects. Around two weeks after birth, many of these differences began to fade.
They also found that changes in brain activity mirrored the molecular processes and that female mice show different responses to ASD-linked mutations.
Looking ahead
ASD shows immense genetic diversity, which makes the search for a one-size-fits-all intervention difficult. The Novarino group’s recent work highlights the shared changes in brain cells that appear across different genetic forms of ASD, pointing toward common developmental pathways that could become targets for early intervention.
“Our findings advocate for therapeutic approaches that are stage-specific, sex-specific, and trajectory-specific. Rather than looking for a single universal intervention, we need to account for when in development we intervene, the biological sex of the individual, and the specific genetic and molecular trajectory that person is on,” explains Novarino.
“Autism spectrum conditions affect many children and families around the globe. Understanding what is happening in their brains matters on two levels: it deepens our knowledge of human brain development more broadly, and it brings us closer to being able to meaningfully support these individuals.”
Key Questions Answered:
A: No. While each genetic mutation leaves behind its own unique molecular fingerprint, this research proves that they ultimately converge on the exact same brain cell types and biological pathways. Instead of causing hundreds of entirely separate conditions, these diverse genetic factors disrupt a shared core network of molecular processes, particularly during the critical windows of early brain development.
A: The disruptions primarily show up as temporary, transient delays in how brain cells mature and connect to one another, rather than permanent structural defects. In preclinical models, many of these stark molecular differences actually began to naturally fade and normalize around two weeks after birth, pointing to a highly flexible but time-sensitive developmental window.
A: Because autism’s underlying biology changes dramatically depending on an individual’s developmental stage, genetic trajectory, and biological sex. The researchers discovered that female brains respond to the exact same high-risk mutations in a fundamentally different molecular manner than male brains, meaning effective future therapies must be customized to a patient’s precise sex and age.
Editorial Notes:
- This article was edited by a Neuroscience News editor.
- Journal paper reviewed in full.
- Additional context added by our staff.
About this autism and genetics research news
Author: Andreas Rothe
Source: ISTA
Contact: Andreas Rothe – ISTA
Image: The image is credited to Neuroscience News
Original Research: Open access.
“Cortical development dynamics across autism spectrum disorder mouse models” by Lena A. Schwarz, Christoph P. Dotter, Sergey Isaev, Michela Lisi, Daniel Malzl, Christoph Büschl, Sabrina Ladstätter, Bárbara Oliveira, Matteo Barel, Bernadette Basilico, Chaitanya Chintaluri, Sarah Gorkiewicz, Mohammad Goudarzi, Tereza Belinova, Stephan Reichl, Gintarė Sendžikaitė, Satish Arcot Jayaram, Peter Koppensteiner, Christoph Sommer, Tim P. Vogels, Jörg Menche, Igor Adameyko, Peter V. Kharchenko, Christoph Bock & Gaia Novarino. Nature
DOI:10.1038/s41586-026-10679-1
Abstract
Cortical development dynamics across autism spectrum disorder mouse models
Despite the functional diversity of over 100 causal genes, phenotypic convergence across models may reveal common neurobiological processes in autism spectrum disorder (ASD). Here we profiled 251 samples from 11 monogenic mouse models of ASD using single-nucleus multi-omic sequencing across three developmental stages, both sexes and two brain regions.
Despite genetic heterogeneity, ASD-linked mutations converged on perturbations of the radial glial cell lineage. These alterations reflect a transient developmental delay rather than lasting lineage misspecification and resolve by postnatal stages. Molecularly, the largest transcriptional differences emerged in neurons at early postnatal stages.
These changes included downregulation of synaptic and ion channel-related genes, consistent with homeostatic adaptation or delayed maturation. Network analysis showed molecular convergence across models within each developmental stage, suggesting that diverse mutations linked to ASD impinge on common, stage-specific processes. Convergence becomes less pronounced by postnatal day 14, highlighting the dynamic nature of ASD-associated changes.
Cross-genotype heterogeneity is superimposed on stage-specific effects. Electrophysiology corroborated this pattern: mutants generally showed altered neuronal excitability and synaptic properties with model-specific nuances.
Our study also highlighted sex-specific gene expression alterations, with female mice often displaying larger effect sizes than male mice. Together, our findings provide a comprehensive view of developmental cellular and molecular dynamics across models of ASD.
